Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDErnexa Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$24.00 | -$24.00 | -$24.00 |
| Q2 2026 | 1 | -$37.50 | -$37.50 | -$37.50 |
| Q3 2026 | 1 | -$48.00 | -$48.00 | -$48.00 |
| Q4 2026 | 1 | -$39.00 | -$39.00 | -$39.00 |
| Q1 2027 | 1 | -$33.00 | -$33.00 | -$33.00 |
| Q2 2027 | 1 | -$36.00 | -$36.00 | -$36.00 |
Ernexa Therapeutics Inc. Earnings Date And Information
Ernexa Therapeutics Inc. last posted its earnings results on Monday, November 14th, 2022. The company reported $-2.49 earnings per share for the quarter, missing analysts' consensus estimates of $-2.2 by $0.29. The company had revenue of 0 for the quarter and had revenue of 582.00 K for the year. Ernexa Therapeutics Inc. has generated $-2 earnings per share over the last year ($-1.57 diluted earnings per share) and currently has a price-to-earnings ratio of -0.59. Ernexa Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based on prior year's report dates.
Ernexa Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2025 | Q3 2025 | N/A | -$0.15 | N/A | N/A | $0 |
| 08/13/2025 | Q2 2025 | N/A | -$0.61 | N/A | N/A | $0 |
| 05/07/2025 | Q1 2025 | N/A | -$0.15 | N/A | N/A | $0 |
| 03/12/2025 | Q4 2024 | N/A | -$0.42 | N/A | N/A | $1.00 K |
| 11/12/2024 | Q3 2024 | N/A | -$4.92 | N/A | $487.00 K | $487.00 K |
| 08/13/2024 | Q2 2024 | N/A | -$1.02 | N/A | $47.00 K | $47.00 K |
| 05/14/2024 | Q1 2024 | N/A | -$1.23 | N/A | N/A | $47.00 K |
| 03/14/2024 | Q4 2023 | N/A | -$1.14 | N/A | N/A | $17.00 K |
| 11/13/2023 | Q3 2023 | N/A | -$1.03 | N/A | N/A | $51.00 K |
| 08/11/2023 | Q2 2023 | N/A | -$0.85 | N/A | N/A | $0 |
| 05/11/2023 | Q1 2023 | N/A | -$1.06 | N/A | N/A | $0 |
| 03/20/2023 | Q4 2022 | N/A | -$1.02 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$2.20 | -$2.49 | -0.29 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$2.60 | $2.41 | 5.01 | N/A | $0 |
| 06/30/2022 | Q1 2022 | -$2.80 | -$4.65 | -1.85 | N/A | $0 |
| 06/30/2022 | Q4 2021 | -$2.80 | -$3.25 | -0.45 | N/A | $0 |
| 11/12/2021 | Q3 2021 | N/A | -$34.05 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$4.75 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$12.74 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$1.60 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ernexa Therapeutics Inc. Earnings: FAQ's
Ernexa Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based offlast year's report dates.
The conference call for Ernexa Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Ernexa Therapeutics Inc.'s latest earnings report can be read online.
Ernexa Therapeutics Inc. (:ERNA) has a recorded annual revenue of $582.00 K.
Ernexa Therapeutics Inc. (:ERNA) has a recorded net income of $-44,539,000.Ernexa Therapeutics Inc. has generated $-1.57 earnings per share over the last four quarters.
Ernexa Therapeutics Inc. (:ERNA) has a price-to-earnings ratio of -0.59 and price/earnings-to-growth ratio is -0.01.